Jtechnow

• Company Name : Jtechnow
• About Us : Sub-Licensing Available Dear Sir, Munogenics, Inc. develops, tests, and licenses novel biological methods for treating and preventing malignant diseases in humans. The company has a proprietary revolutionary platform for cancer treatment that shows exceptional efficacy and minimal side effect in treating cancers. In collaboration with a research team led by Dr. Zheng Cui, MD / PhD and Dr. Mark C. Willingham, MD, at Wake Forest University, Munogenics will commercialize a new cancer treatment, termed the GIFT (Granulocyte InFusion Therapy) process, and the CKA (Cancer Killing Activity) test with the Jtechnow currently seeking to sub-license GIFT and CKA testing in select countries around the world. Our research clearly demonstrates that granulocyte infusion, at optimal levels, translates to an unprecedented regression of cancer. To obtain more information about bringing GIFT to a country, please contact us. We will be happy to provide all of the information you need. we await your reply Lathell Sancho
• Product/Service : Cancer Cure Treatment, Raw Materials,Bio PET Products, cancer Cure,Hair Care Product,Antioxidant Pet Wafer, Dismutase,Dismutase Granular, Feline Heath Food, Canine Health Food, Raw Material,Exercise Edge, Runner Edge, Pacific Sea Plasma
• Country/Region : United States >
• Category : Chemicals
• Contact Person : Mr. Lathell sancho |||Director/CEO/General Manager
• Link More : United States Chemicals ,United States Pharmaceutical Chemicals
• Telephone :
• Fax :
• Mobile phone :
• Address : 1951 N. Jones Blvd
• Website :
• Business Type : Manufacturer

Pharmaceutical Chemicals Related Company